Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Title: Preface
Volume: 1 Issue: 1
Author(s): Michael J. Quon and Emilio Jirillo
Affiliation:
Export Options
About this article
Cite this article as:
Quon J. Michael and Jirillo Emilio, Preface, Current Drug Targets - Immune, Endocrine & Metabolic Disorders 2001; 1 (1) . https://dx.doi.org/10.2174/1568005013343317
DOI https://dx.doi.org/10.2174/1568005013343317 |
Print ISSN 1568-0088 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5917 |
9
Related Articles
-
MiR-492 as an Important Biomarker for Early Diagnosis and Targeted Treatment in Different Cancers
Current Cancer Therapy Reviews Ceramide: Therapeutic Potential in Combination Therapy for Cancer Treatment
Current Drug Metabolism Identification of Key mRNAs, miRNAs, and mRNA-miRNA Network Involved in Papillary Thyroid Carcinoma
Current Bioinformatics Silver and Other Metals in the Treatment of Gastrointestinal Diseases
Current Medicinal Chemistry Autophagy : Moving Benchside Promises to Patient Bedsides
Current Cancer Drug Targets Inhibition of PI3K/Akt Signaling: An Emerging Paradigm for Targeted Cancer Therapy
Current Medicinal Chemistry - Anti-Cancer Agents Metabolomics and Its Practical Value in Pharmaceutical Industry
Current Drug Metabolism Molecularly Targeted Therapy for Gastrointestinal Cancer
Current Cancer Drug Targets Genetic and Epigenetic Signatures in Human Hepatocellular Carcinoma:A Systematic Review
Current Genomics Pharmacogenetics, Pharmacogenomics and Epigenetics of Nrf2-regulated Xenobioticmetabolizing Enzymes and Transporters by Dietary Phytochemical and Cancer Chemoprevention
Current Drug Metabolism Overall and Multiphasic Findings of the Prostate, Lung, Colorectal and Ovarian (PLCO) Randomized Cancer Screening Trial
Reviews on Recent Clinical Trials Significance of Genome-Wide Analysis of Copy Number Alterations and UPD in Myelodysplastic Syndromes using Combined CGH – SNP Arrays
Current Medicinal Chemistry Processed Foods, Dysbiosis, Systemic Inflammation, and Poor Health
Current Nutrition & Food Science Regulation of Apoptosis by SYB in HepG2 Liver Cancer Cells is Mediated by the P53/Caspase 9 Axis
Anti-Cancer Agents in Medicinal Chemistry Current Status of Clinical Trials for Glioblastoma
Reviews on Recent Clinical Trials The Ubiquitin+Proteasome Protein Degradation Pathway as a Therapeutic Strategy in the Treatment of Solid Tumor Malignancies
Anti-Cancer Agents in Medicinal Chemistry 3dswap-pred: Prediction of 3D Domain Swapping from Protein Sequence Using Random Forest Approach
Protein & Peptide Letters Tubulin Colchicine Binding Site Inhibitors as Vascular Disrupting Agents in Clinical Developments
Current Medicinal Chemistry An efficient Synthesis of New Fused Oxazinocarbazoles
Letters in Organic Chemistry The Changing Face of HDAC Inhibitor Depsipeptide
Current Cancer Drug Targets